Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Nippon Chemiphar presents novel P2X4 receptor antagonists

March 16, 2009

Dainippon launches Trerief in Japan for Parkinson's disease

March 16, 2009

Auris Medical initiates phase IIb AM-101 trial in acute inner ear tinnitus

March 16, 2009

Mechanism of action, activity of the coumarin scopoletin described

March 16, 2009

Coeloglossum viride extract protective in models of brain ischemia

March 16, 2009

GPR3 identified as a new pharmacological target for Alzheimer's disease

March 16, 2009

Novartis presents novel GABA-A receptor ligands

March 13, 2009

Novel beta-secretase inhibitors claimed by CoMentis and Purdue Research Foundation

March 13, 2009

Neurogen presents novel heteroaryl amide analogues

March 13, 2009

Preliminary findings suggest AD-01, AD-02 vaccines are safe in Alzheimer's disease patients

March 13, 2009

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026